ArticleTheranostics2021

EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.

Yiping Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.